During the past decade, Beacon Clinical Research, LLC conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 36 clinical trials were completed, i.e. on average, 211.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 16 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beacon Clinical Research, LLC" #1 sponsor was "Pfizer" with 12 trials, followed by "Eli Lilly and Company" with 6 trials sponsored, "Allergan" with 3 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 3 trials sponsored and "Purdue Pharma LP" with 3 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beacon Clinical Research, LLC" #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Beacon Clinical Research, LLC" are "Atopic Dermatitis" (5 trials), "Osteoarthritis" (5 trials), "Chronic Idiopathic Constipation" (3 trials), "Chronic Low Back Pain" (3 trials) and "Chronic Pain" (3 trials). Many other conditions were trialed in "Beacon Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "Beacon Clinical Research, LLC" are "Drug" (40 trials), "Biological" (9 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "placebo" (4 trials), "Lebrikizumab" (3 trials), "pregabalin" (3 trials) and "Hydrocodone ER" (2 trials). Other intervention names were less common.

The vast majority of trials in "Beacon Clinical Research, LLC" are 45 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Beacon Clinical Research, LLC". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in Beacon Clinical Research, LLC, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Beacon Clinical Research, LLC, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".